Mutation screening and clinical features analysis in patients with early-onset primary dystonia
Objective: In this context, it is important to reveal the mutation frequency of primary dystonia related genes using target dystonia related gene panel among a…Late-Onset Dopa-Responsive Dystonia: A Case Report
Objective: To present a rare cause of treatable dystonia with onset during adulthood. Background: L-Dopa-responsive dystonia is an inherited disorder characterized by early-onset dystonia affecting…An aberrant embouchure dystonia network predicts objective and functional measures of severity
Objective: To investigate functional brain networks underlying focal embouchure dystonia (FED) using resting-state functional connectivity (FC) magnetic resonance imaging and to correlate abnormal connectivity with…What is holding back apomorphine therapy for Parkinson’s disease? Identifying knowledge gaps amongst Thai neurological medical professionals
Objective: To assess the level of understanding about, and identify knowledge gaps in, apomorphine therapy amongst Thai neurological medical professionals. Background: Continuous subcutaneous apomorphine infusion…Parkinson’s Disease in the Middle East, North Africa and South Asia: A Scoping Review
Objective: To summarize the literature on PD in the Middle East, North Africa and South Asia (MENASA) countries including its epidemiology, clinical characteristics and unique…Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research
Objective: To develop a quantitative method for designing appropriate longitudinal follow-up frequency. We demonstrate how to use this new method using a progression study of…Primary familial brain calcifications in Sweden
Objective: Our main aim was to define the clinical presentation and genotypes of a cohort with primary familial brain calcifications (PFBC) at a tertiary center…Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US
Objective: Describe the comorbidity burden for patients (pt) and care partners (cp) of Huntington’s Disease (HD), Parkinson’s Disease (PD) and the general population (GP) Background:…Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF study
Objective: To present the mutant huntingtin (mHTT) and neurofilament light (NfL) findings from the two-year prospective longitudinal HD-CSF study, in which an 80-participant cohort of…Transcranial sonography in HIV infection: Does it reflect infectious and neurological symptoms?
Objective: To study whether transcranial sonography of brain parenchyma shows features with a potential association with clinical and neurological variables in human immunodeficiency virus (HIV)…
- « Previous Page
- 1
- …
- 130
- 131
- 132
- 133
- 134
- …
- 149
- Next Page »